Net profit of Aarti Drugs rose 14.38% to Rs 27.44 crore in the quarter ended March 2019 as against Rs 23.99 crore during the previous quarter ended March 2018. Sales rose 38.84% to Rs 459.14 crore in the quarter ended March 2019 as against Rs 330.69 crore during the previous quarter ended March 2018.

For the full year,net profit rose 9.04% to Rs 89.75 crore in the year ended March 2019 as against Rs 82.31 crore during the previous year ended March 2018. Sales rose 25.51% to Rs 1560.94 crore in the year ended March 2019 as against Rs 1243.63 crore during the previous year ended March 2018.

Powered by Capital Market - Live News

Aarti Drugs announced that the Board of Directors of the Company at its meeting held on 15 May 2019, has recommended a Final dividend of Rs.1 per share (i.e.10%), subject to the approval of the shareholders.

Powered by Capital Market - Live News

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 15 May 2019.

Powered by Capital Market - Live News

Aarti Drugs announced that Vibhav S. Ranade, has tendered his resignation as the Company Secretary & Compliance Officer of the Company w.e.f. 27 March 2019.

Powered by Capital Market - Live News